VarCov Co’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
VarCov Co's RXRX Position: Q3 2026 in Review
VarCov Co increased its Recursion Pharmaceuticals (RXRX) stake by 154% in Q3 2026, buying an estimated $223K and bringing the position to 108,713 shares worth $449K. The position accounts for 0.22% of the portfolio, ranked #158.
VarCov Co first reported a position in RXRX in Q4 2025 and has held it in 4 quarters since. The position peaked at $527K in Q1 2026. 353 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- VarCov Co held 108,713 shares of Recursion Pharmaceuticals worth $449K as of Q3 2026.
- VarCov Co bought 65,876 Recursion Pharmaceuticals shares in Q3 2026, an estimated $223K.
- Recursion Pharmaceuticals made up 0.22% of VarCov Co's portfolio in Q3 2026, its #158 holding.
- VarCov Co first reported a position in Recursion Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- VarCov Co's Recursion Pharmaceuticals position peaked at $527K in Q1 2026.
- 353 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.